Allurion Technologies, Inc. Other Nonoperating Income (Expense)
Allurion Technologies, Inc. (ALUR) reported Other Nonoperating Income (Expense) of $49.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-05-15
- Allurion Technologies, Inc. other nonoperating income (expense) for the quarter ending 2026-03-31 was $49.00K.
- Allurion Technologies, Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was $462.00K.
- Allurion Technologies, Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was $112.00K, a 85.20% decline year-over-year.
- Allurion Technologies, Inc. other nonoperating income (expense) for the quarter ending 2025-06-30 was $621.00K, a 37.84% decline year-over-year.
- Allurion Technologies, Inc. other nonoperating income (expense) for fiscal 2025 was $982.00K, a 32.37% decline from fiscal 2024.
- Allurion Technologies, Inc. other nonoperating income (expense) for fiscal 2024 was $1.45M.
- Allurion Technologies, Inc. other nonoperating income (expense) for fiscal 2023 was -$643.00K.
- Allurion Technologies, Inc. other nonoperating income (expense) for fiscal 2022 was -$344.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|---|---|
| 2026-03-31 | $49.00K 10-Q · filed 2026-05-15 | $511.00K derived: sum of 2 quarters · filed 2026-05-15 | $623.00K derived: sum of 3 quarters · filed 2026-05-15 | $1.24M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-12-31 | $462.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $574.00K derived: sum of 2 quarters · filed 2026-03-30 | $1.20M derived: sum of 3 quarters · filed 2026-03-30 | $982.00K 10-K · filed 2026-03-30 | ||
| 2025-09-30 | $112.00K 10-Q · filed 2025-11-17 | $733.00K derived: sum of 2 quarters · filed 2025-11-17 | $520.00K 10-Q · filed 2025-11-17 | $44.00K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-06-30 | $621.00K 10-Q · filed 2025-08-19 | $408.00K 10-Q · filed 2025-08-19 | -$68.00K derived: sum of 3 quarters · filed 2026-05-15 | $689.00K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-03-31 | -$213.00K 10-Q · filed 2026-05-15 | -$689.00K derived: sum of 2 quarters · filed 2026-05-15 | $68.00K derived: sum of 3 quarters · filed 2026-05-15 | $1.07M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$476.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $281.00K derived: sum of 2 quarters · filed 2026-03-30 | $1.28M derived: sum of 3 quarters · filed 2026-03-30 | $1.45M 10-K · filed 2026-03-30 | ||
| 2024-09-30 | $757.00K 10-Q · filed 2025-11-17 | $1.76M derived: sum of 2 quarters · filed 2025-11-17 | $1.93M 10-Q · filed 2025-11-17 | $1.15M derived: sum of 4 quarters · filed 2025-11-17 | ||
| 2024-06-30 | $999.00K 10-Q/A · filed 2025-08-28 | $1.17M 10-Q/A · filed 2025-08-28 | $395.00K derived: sum of 3 quarters · filed 2025-08-28 | $784.00K derived: sum of 4 quarters · filed 2025-08-28 | ||
| 2024-03-31 | $172.00K 10-Q/A · filed 2025-08-28 | -$604.00K derived: sum of 2 quarters · filed 2025-08-28 | -$215.00K derived: sum of 3 quarters · filed 2025-08-28 | -$306.00K derived: sum of 4 quarters · filed 2025-08-28 | ||
| 2023-12-31 | -$776.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | -$387.00K derived: sum of 2 quarters · filed 2025-08-28 | -$478.00K derived: sum of 3 quarters · filed 2025-08-28 | -$643.00K 10-K/A · filed 2025-08-28 | ||
| 2023-09-30 | $389.00K 10-Q/A · filed 2025-08-28 | $298.00K derived: sum of 2 quarters · filed 2025-08-28 | $133.00K 10-Q/A · filed 2025-08-28 | $664.00K derived: sum of 4 quarters · filed 2025-08-28 | ||
| 2023-06-30 | -$91.00K 10-Q/A · filed 2025-08-28 | -$85.00K 10-Q · filed 2023-10-20 | -$255.00K 10-Q/A · filed 2025-08-28 | -$220.00K 10-Q · filed 2023-10-20 | $275.00K derived: sum of 3 quarters · filed 2025-08-28 | -$145.00K derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-03-31 | -$164.00K 10-Q/A · filed 2025-08-28 | $366.00K derived: sum of 2 quarters · filed 2025-08-28 | -$54.00K derived: sum of 3 quarters · filed 2025-08-28 | -$341.00K derived: sum of 4 quarters · filed 2025-08-28 | ||
| 2022-12-31 | $530.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | $110.00K derived: sum of 2 quarters · filed 2025-08-28 | -$177.00K derived: sum of 3 quarters · filed 2025-08-28 | -$344.00K 10-K/A · filed 2025-08-28 | ||
| 2022-09-30 | -$420.00K 10-Q · filed 2023-11-14 | -$707.00K derived: sum of 2 quarters · filed 2023-11-14 | -$874.00K 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | -$287.00K 10-Q · filed 2023-10-20 | -$454.00K 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |